(Top Pick Jun 1/16, Up 7%) He bought and sold it a few different times in the last year. They make several drugs. They have several trials with positive news having come out in the last year. One or two new drugs will get approved in the next year. He still likes it, but keep in mind the aggressiveness that comes with it.
A UK company. They use synthetic cannabinoids to create drugs that are used to fight seizures and pain. This has been lumped into the cannabis/marijuana sector. Had their phase 3 updated results for a drug for seizures in children under 1 year of age. In the next month, there are 2 phase 3 trials that are coming in from the FDA, and he believes that 1, possibly 2 are going to be approved.
GW Pharmaceuticals PLC is a American stock, trading under the symbol GWPH-Q on the NASDAQ (GWPH). It is usually referred to as NASDAQ:GWPH or GWPH-Q
In the last year, there was no coverage of GW Pharmaceuticals PLC published on Stockchase.
GW Pharmaceuticals PLC was recommended as a Top Pick by on . Read the latest stock experts ratings for GW Pharmaceuticals PLC.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered GW Pharmaceuticals PLC In the last year. It is a trending stock that is worth watching.
On 2021-05-04, GW Pharmaceuticals PLC (GWPH-Q) stock closed at a price of $219.01.